While the S&P 500 rose 24% in 2023, the S&P 500 Pharmaceuticals industry index slipped 2.2%. Lilly and Novo Nordisk were the exceptions in a slumping.
Callan Capital LLC boosted its stake in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 177.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,893 shares of the company’s stock after buying an additional 3,771 shares during the period. […]
PFG Investments LLC grew its stake in Novo Nordisk A/S (NYSE:NVO – Free Report) by 104.7% during the 3rd quarter, Holdings Channel reports. The firm owned 13,674 shares of the company’s stock after purchasing an additional 6,994 shares during the quarter. PFG Investments LLC’s holdings in Novo Nordisk A/S were worth $1,244,000 at the end […]
Sivik Global Healthcare LLC increased its stake in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 80.0% during the 3rd quarter, Holdings Channel reports. The fund owned 90,000 shares of the company’s stock after acquiring an additional 40,000 shares during the period. Novo Nordisk A/S comprises approximately 4.1% of Sivik Global Healthcare LLC’s […]
Schrum Private Wealth Management LLC purchased a new position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor purchased 2,402 shares of the company’s stock, valued at approximately $218,000. A number of other institutional investors have also recently added to or reduced their stakes in […]